GSK

Our mission and ambition
GlaxoSmithKline (GSK) is a global biopharmaceutical company with a mission to "unite science, technology, and talent to get ahead of disease together."

We are committed to positively impacting the health of 2.5 billion people over the next decade. Our new commitment to growth and transformative performance demonstrates our high aspirations for patients. At the same time, we are a company where outstanding talent can thrive and reach their full potential.

In China, we have always been dedicated to helping improve the health, lives, and future of the Chinese people.

Our presence in China
Business covers more than 250 cities and regions across China
5 regional centers: Beijing, Shanghai, Chengdu, Guangzhou, Hangzhou
1 national commercial operations center in Shanghai
1 research and development center in Shanghai
1 institute for infectious diseases and public health in Beijing

Our business in China
Vaccines: We are committed to increasing the accessibility of vaccines for Chinese patients and consumers. Our pediatric and adult vaccines can prevent a variety of diseases: shingles vaccine, cervical cancer vaccine, and hepatitis B vaccines available in both adult and pediatric formulations.
Prescription medicines: Our prescription medicine business has a rich portfolio of innovative and mature products. In China, we currently focus on the following therapeutic areas: respiratory, hepatitis, neurological diseases, HIV/AIDS, immune system diseases including systemic lupus erythematosus, and rare diseases including pulmonary arterial hypertension and eosinophilic granulomatosis with polyangiitis (EGPA).